Literature DB >> 7780983

Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy.

T Hongyo1, G S Buzard, D Palli, C M Weghorst, A Amorosi, M Galli, N E Caporaso, J F Fraumeni, J M Rice.   

Abstract

K-ras and p53 gene mutations in intestinal-type gastric carcinomas from a high-incidence area around Florence, Italy, were studied by single strand conformation polymorphism and DNA sequencing analysis. Single-strand conformation polymorphism analysis of K-ras indicated aberrant bands in 13 of 34 cases. Sequencing revealed point mutations in 7 (including two at a previously unreported site in codon 11), a significantly higher frequency than reported in countries other than Japan. No K-ras mutations were identified in stage III tumors. Single-strand conformation polymorphisms in p53 exons 5-8 occurred in 30 of 34 cases, with mutations identifiable by direct sequencing in 65% of the cases. Of these, 91% were base substitutions, a value similar to that usually reported, but the percentage of G:C to A:T transitions (90% in this study, 89% in all published European cases combined) differed significantly from that in Oriental cases (48%). The percentage of A:T to G:C transitions was greater in Oriental (22%) than European cases (2%), as was also true for transversions (30% in Oriental tumors, 9% in European tumors). The frequency of mutations at CpG sites (14%) varied significantly from the 67% in cases from a neighboring region in Italy. Helicobacter pylori infection was established in 19 cases and was somewhat more common in cases lacking a p53 mutation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780983

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  Infrequent p53 gene mutation and expression of the cardia adenocarcinomas from a high-incidence area of Southwest China.

Authors:  Xiu-Jie Wang; Shu-Lan Yuan; Chang-Ping Li; Naoko Iida; Hideaki Oda; Shigetoshi Aiso; Takatoshi Ishikawa
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?

Authors:  Hilda Wong; Thomas Yau
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

Review 3.  Hypermutability in carcinogenesis.

Authors:  B S Strauss
Journal:  Genetics       Date:  1998-04       Impact factor: 4.562

4.  EGFR and Notch signaling respectively regulate proliferative activity and multiple cell lineage differentiation of Drosophila gastric stem cells.

Authors:  Chenhui Wang; Xingting Guo; Rongwen Xi
Journal:  Cell Res       Date:  2014-03-07       Impact factor: 25.617

Review 5.  Anti-HER agents in gastric cancer: from bench to bedside.

Authors:  Lorenzo Fornaro; Maurizio Lucchesi; Chiara Caparello; Enrico Vasile; Sara Caponi; Laura Ginocchi; Gianluca Masi; Alfredo Falcone
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06-07       Impact factor: 46.802

Review 6.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

7.  TGF-beta signaling pathway inactivation and cell cycle deregulation in the development of gastric cancer: role of the beta-spectrin, ELF.

Authors:  Sang Soo Kim; Kirti Shetty; Varalakshmi Katuri; Krit Kitisin; Hye Jung Baek; Yi Tang; Blair Marshall; Lynt Johnson; Bibhuti Mishra; Lopa Mishra
Journal:  Biochem Biophys Res Commun       Date:  2006-04-19       Impact factor: 3.575

8.  Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC.

Authors:  Chong Lu; Hui-Mian Xu; Qun Ren; Yang Ao; Zhen-Ning Wang; Xue Ao; Li Jiang; Yang Luo; Xue Zhang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

Review 9.  Clinical Outcomes of TP53 Mutations in Cancers.

Authors:  Ana I Robles; Jin Jen; Curtis C Harris
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

10.  Fast simultaneous detection of K-RAS mutations in colorectal cancer.

Authors:  Ya-Sian Chang; Kun-Tu Yeh; Tien-Jye Chang; Connie Chai; Hsiu-Chin Lu; Nicholas C Hsu; Jan-Gowth Chang
Journal:  BMC Cancer       Date:  2009-06-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.